View clinical trials related to Deep Mycosis.
Filter by:The objective of this study is to investigate the safety and efficacy of administering 372.6 mg of AK1820 (isavuconazonium sulfate) intravenously or orally to adult Japanese patients with deep mycosis. The primary endpoint is safety (percentage of patients with adverse events after starting the study treatment).
To collect the efficacy and safety information of fluconazole on infant subjects related to their appropriate use in daily practice.